Secondary prevention after coronary bypass: the American Heart Association "Get with the Guidelines" program.

[1]  V. Fuster,et al.  AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Circulation.

[2]  V. Fuster,et al.  AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Journal of the American College of Cardiology.

[3]  Michael F. Oliver,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. , 2001, Indian heart journal.

[4]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[5]  B. Horne,et al.  Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. , 2001, The American journal of cardiology.

[6]  D W Bates,et al.  Use and monitoring of "statin" lipid-lowering drugs compared with guidelines. , 2001, Archives of internal medicine.

[7]  W. R. Smith,et al.  Evidence for the effectiveness of techniques To change physician behavior. , 2000, Chest.

[8]  C. Roberts.  Postoperative drug therapy to extend survival after coronary artery bypass grafting. , 2000, The Annals of thoracic surgery.

[9]  T. Pearson,et al.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. , 2000, Archives of internal medicine.

[10]  J. Pugh,et al.  Attitudes of Primary Care Providers Toward Diabetes: Barriers to guideline implementation , 1998, Diabetes Care.

[11]  T. Pearson,et al.  The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. , 1997, The American journal of cardiology.

[12]  H. Krumholz,et al.  When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. , 1997, Circulation.